IQ-AI Ltd
LSE:IQAI
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
EV/OCF
Enterprise Value to Operating Cash Flow (EV/OCF) ratio compares a company`s total enterprise value to its operating cash flow. It shows how much investors are paying for each dollar of the company`s operating cash flow, including both equity and debt.
Enterprise Value to Operating Cash Flow (EV/OCF) ratio compares a company`s total enterprise value to its operating cash flow. It shows how much investors are paying for each dollar of the company`s operating cash flow, including both equity and debt.
Valuation Scenarios
If EV/OCF returns to its 3-Year Average (17), the stock would be worth GBX0.43 (47% downside from current price).
| Scenario | EV/OCF Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 32.2 | GBX0.83 |
0%
|
| 3-Year Average | 17 | GBX0.43 |
-47%
|
| Industry Average | 551.2 | GBX14.12 |
+1 611%
|
| Country Average | 0.2 | GBX0 |
-99%
|
Forward EV/OCF
Today’s price vs future operating cash flow
Peer Comparison
| Market Cap | EV/OCF | P/E | ||||
|---|---|---|---|---|---|---|
| JE |
|
IQ-AI Ltd
LSE:IQAI
|
2m GBP | 32.2 | -1.9 | |
| JP |
|
Medical Data Vision Co Ltd
TSE:3902
|
37.9T JPY | 79.3 | 227.5 | |
| US |
C
|
Cerner Corp
LSE:0R00
|
31.3B USD | 18.9 | 53.1 | |
| US |
|
Veeva Systems Inc
NYSE:VEEV
|
26.3B USD | 13.8 | 28.9 | |
| AU |
|
Pro Medicus Ltd
ASX:PME
|
14.4B AUD | 111.1 | 61.5 | |
| JP |
|
M3 Inc
TSE:2413
|
1T JPY | 13.8 | 20.7 | |
| SE |
|
Sectra AB
STO:SECT B
|
50.6B SEK | 61.7 | 94.2 | |
| US |
W
|
Waystar Holding Corp
NASDAQ:WAY
|
4.9B USD | 20 | 42.9 | |
| US |
|
Doximity Inc
NYSE:DOCS
|
4.6B USD | 12.1 | 19.1 | |
| US |
V
|
Vocera Communications Inc
F:V00
|
2.4B EUR | 61.3 | -328 | |
| CN |
|
Winning Health Technology Group Co Ltd
SZSE:300253
|
18.7B CNY | 37 | -60.8 |
Market Distribution
| Min | 0 |
| 30th Percentile | 0 |
| Median | 0.2 |
| 70th Percentile | 5.7 |
| Max | 551.2 |
Other Multiples
IQ-AI Ltd
Glance View
IQ-AI Ltd. is a holding company, which engages in the provision of clinical treatments to patients in the field of medical imaging diagnostics. The firm provides health care technology solutions to the artificial intelligence (AI) medical imaging market. Through its subsidiary, StoneChecker Software Ltd, It offers medical imaging software for urolithiasis that analyses and presents stone metrics, including stone size, volume, density, skin to stone distance, and stone architecture through TexRAD analysis within the healthcare information technology (IT) systems. Through its subsidiary, Imaging Biometrics, LLC, It specializes in the design and manufacture of visualization tools, the application of machine learning and AI software solutions, and the development and clinical testing of imaging endpoints and biomarkers. Its portfolio consists of IB Neuro and IB Diffusion that are used in treatment of brain tumors, strokes and pathologies.
